Persistent URL of this record https://hdl.handle.net/1887/96465
In Collections
This item can be found in the following collections:
Loss of chromosome 18q11.2-18q12.1 is predictive for progression-free survival in metastatic colorectal cancer patients treated with bevacizumab
- All authors
- Dijk, E. van; Biesma, H.; Cordes, M.; Smeets, D.; Neerincx, M.; S. das; Murphy, V.; Barat, A.; Bacon, O.; Prehn, J.H.M.; Betge, J.; Timo, G.; Fender, B.; Meijer, G.A.; McNamara, D.A.; Klinger, R.; Koopman, M.; Ebert, M.P.A.; Kay, E.W.; Hennessey, B.T.; Verheul, H.M.W.; Gallagher, W.M.; O'Connor, D.P.; Punt, C.J.A.; Loupakis, F.; Lambrechts, D.; Byrne, A.; Grieken, N.C.T. van; Ylstra, B.
- Date
- 2018-07-31
- Journal
- Cancer Research
- Volume
- 78
- Issue
- 13